Showing results (1191-1200 of 1,607) with videos related to
Sort By:
Pageof 161
RSC Medicinal Chemistry|October 27, 2026
Recent advances in scaffold-based KRASG12C inhibitors: SAR and biological evaluation insightsTomojit Bhattacharjee, Ankush Kumar, Thakur Gurjeet Singh, et al.RSC Medicinal Chemistry|October 31, 2026
Structure and connected hydrophobicity promote endocytic uptake of single-arginine cyclic hexapeptides: lessons from wollamide B1 analoguesLiping Liu, Huy N Hoang, Lewis Goodwin, et al.RSC Medicinal Chemistry|June 13, 2022
Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogsKhaled M Elattar, Ayman Y El-Khateeb, Sahar E HamedRSC Medicinal Chemistry|June 13, 2022
Tackling antimicrobial stewardship through synergy and antimicrobial peptidesJenna M Greve, James A CowanRSC Medicinal Chemistry|August 3, 2022
De novo design of type II topoisomerase inhibitors as potential antimicrobial agents targeting a novel binding regionKyle M Orritt, Lipeng Feng, Juliette F Newell, et al.RSC Medicinal Chemistry|August 6, 2021
A review of the latest research on Mpro targeting SARS-COV inhibitorsHuihui Yang, Jinfei YangRSC Medicinal Chemistry|August 6, 2021
Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapySang-Yong Lee, Vigneshwaran Namasivayam, Nader M Boshta, et al.RSC Medicinal Chemistry|August 6, 2021
The development of HEC-866 and its analogues for the treatment of idiopathic pulmonary fibrosisRunfeng Lin, Zheng Zhang, Shengtian Cao, et al.RSC Medicinal Chemistry|November 15, 2021
Design, synthesis, and antibacterial activity of N-(trifluoromethyl)phenyl substituted pyrazole derivativesIbrahim Saleh, Hansa Raj Kc, Subrata Roy, et al.RSC Medicinal Chemistry|November 15, 2021
Design and optimisation of a small-molecule TLR2/4 antagonist for anti-tumour therapyQun Xu, Tian Li, Hekai Chen, et al.Pageof 161